Supporting innovative science
Outstanding experts make up CARB-X’s Advisory Boards, which include both a pre-award Advisory Board that reviews proposals and a post-award Advisory Board that reviews milestone achievement and Option plans. The Advisory Board ensures the highest scientific standards in evaluating applications for CARB-X funding. Every member of the CARB-X Advisory Board completes a conflict-of-interest-process and is excluded from participation in the review or approval of any application with which they have a conflict of interest. They also sign a non-disclosure agreement. We thank them sincerely for their work.
This is a snapshot of reviewers who participated in the 2019 funding rounds. They are exemplary of the types of expertise we use on our Advisory Board
Robert Ballas
Biomarker Associates, Inc.
Michael Barbachyn
Calvin College
Ellen Jo Baron
Prof. Emerita, Stanford University School of Medicine
Greg Basarab
Drug Discovery & Development Centre (H3D); University of Cape Town (UCT)
Keith A Bostian
Institute for Life Science Entrepreneurship
Patricia Bradford
Antimicrobial Development Specialists, LLC
Pamela Brown
Independent Consultant, Pam Brown Consulting Ltd
Karen Bush
Indiana University
Joseph Campbell
DMID NIAID
Adam Clark
HHS/ASPR/BARDA
Bob Clay
Highbury Regulatory Science
Peter Coderre
Antimicrobial Regulatory Consulting
David Cook
Forma Therapeutics
Timothy Cooke
Ology Bioservices
Robin Cooper
Cooper Consulting Inc
Lloyd Czaplewski
Chemical Biology Ventures Ltd
Shampa Das
PKPD Ltd
Joseph Anthony Devito
Independent Consultant
Thomas J Dougherty
Dept of Microbiology Harvard Medical School
Jacques Dumas
Arrakis Therapeutics
Paul Eder
HHS/ASPR/BARDA
Alice L Erwin
Erwin Consulting, LLC
Marta Fernandez Suarez
FIND
Tony Ford-Hutchinson
Independent Consultant
Francois Franceschi
GARDP
Carrie Furr
Bacteriophage & Drug Development Consultants LLC
Humphrey Gardner
Silicone Therapeutics
Debbie Goff
The Ohio State University Wexner Medical Center, OSU College of Pharmacy
Alan Goldberg
HHS/ASPR/BARDA
Mark Goldberger
MPH LLC
Herman Goossens
University Hospital Antwerp
Howard Haimes
SAIC
Sally Hojvat
Partners in Diagnostics, LLC
Amanda Hortsman
Department of Defense (DTRA)
Joe Iaconis
Independent Consultant
Richard James
Developing Novel Antibiotics Consultancy
Zoltan Kanyo
Independent Consultant
Randall Kincaid
Independent Consultant
Jacqueline Kirchner
Bill and Melinda Gates Foundation
Toni Kline
Independent Consultant
Marina Kozak
HHS/ASPR/BARDA
Sushmita Lahiri
Boehringer Ingelheim
Malen Link
ONRG
Mathew Lo
Exosis Inc
Richard Malley
Boston Children’s Hospital and Harvard Medical School
Frederic J Marsik
Independent Consultant
Marielena Mata
Pfizer
Helen McShane
University of Oxford
Chris Meda
IncellDx
Mike Merchlinsky
HHS/ASPR/BARDA
Linda Miller
CMID Pharma Consulting, LLC
Paul Miller
Artizan Biosciences
Marshall Morningstar
Independent Consultant
Larry Mortin
McCarthy Consultants
Wright Nichols
Independent Consultant
Sylvia Norman
Sandhill Crane Diagnostics, Inc.
Anna O’rourke
HHS/ASPR/BARDA
Jordan Plieskatt
Praestans Biosciences LLC
Krishna Prasad
Citranvi, LLC
Steven J Projan
Beat the Reaper
George Franklin Risi
HHS/ASPR/BARDA
Alec Ritchie
NIAID/NIH
Bill Rodriguez
Draper Richards Kaplan Foundation
Claire Sadler
Independent Consultant
Patrick Sanz
NIAID/NIH
Karen Joy Shaw
Hearts Consulting Group
Anita Sheoran
HHS/ASPR/BARDA
Nicola Shepherd
Bellows Consulting
David Shlaes
Anti-Infectives Consulting LLC
Lynn L Silver
LL Silver Consulting, LLC
Jared Adam Silverman
Gates Medical Research Institute
Kathryn Stein
Kathryn Stein Consulting
Robert Suva
Independent Consultant
Brian Tse
HHS/ASPR/BARDA
Janet White
Bill & Melinda Gates Foundation
Sabiha Yusuf Essack
University of KwaZulu-Natal (UKZN)